Login / Signup

Separate and combined effects of long-term GIP and GLP-1 receptor activation in patients with type 2 diabetes: a structured summary of a study protocol for a double-blind, randomised, placebo-controlled clinical trial.

Mads M HelstedLaerke Smidt GasbjergTina VilsbøllCasper K NielsenJulie L FormanMikkel B ChristensenFilip K Krag Knop
Published in: BMJ open (2023)
NCT05078255 and U1111-1259-1491.
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • phase ii
  • phase iii
  • study protocol
  • open label
  • phase ii study
  • randomized controlled trial
  • binding protein